Hopital Europeen Georges-Pompidou (HEGP)

Paris 75015

1 studies enrolling now · 5 studies all time

What they study most

Breast Cancer, Metastatic, Carcinoma, Hepatocellular, Colorectal Neoplasms, Endometrial Neoplasms, Liver Neoplasms, Metastatic Cholangiocarcinoma, Metastatic Urothelial Carcinoma, Neoplasms, Unresectable Cholangiocarcinoma, Unresectable Urothelial Carcinoma, Urothelial Carcinoma

Studies at this site

• ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer — Recruiting now
• A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid Tumor — Running, not enrolling
• Pemigatinib + Pembrolizumab vs Pemigatinib Alone vs Standard of Care for Urothelial Carcinoma (FIGHT-205) — Stopped early
• An Umbrella Study to Determine the Safety and Efficacy of Various Monotherapy or Combination Therapies in Neoadjuvant Urothelial Carcinoma — Stopped early
• A Study to Evaluate the Efficacy and Safety of Pemigatinib Versus Chemotherapy in Unresectable or Metastatic Cholangiocarcinoma — Stopped early